The Delhi High Court has allowed the Cancer Patients Aids Association, an NGO working for the welfare and rights of thousands of cancer patients in India, as party to the on-going legal battle between the multinational pharma company Bayer and the Indian generic major Cipla over the Bayer's kidney cancer drug Nexavar (Sorafenib tosylate).
The details can be read here.
No comments:
Post a Comment